32. Autophagic vacuolar myopathy Disease details / Clinical trials / Drug dev / DR info /

Clinical trial : 1 /  Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0

Drugs and their primary sponsors and trial info
RP-A501   
   Rocket Pharmaceuticals Inc.
      2019   Phase 1   NCT03882437   United States;